Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG42774

CBX5 Knockout CaSki Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Squamous cell carcinoma

This product comprises a CRISPR/Cas9-edited polyclonal knockout cell population of CBX5 (HP1??) in the Ca Ski human cervical carcinoma cell line. CBX5 binds H3K9me3 to mediate heterochromatin formation and gene silencing, acting downstream of methyltransferases SUV39H1 and SETDB1 and interacting with factors such as DNMT1 and Lamin B receptor. The knockout model enables studies of heterochromatin disruption in cancer, including drug screening and mechanistic investigation of epigenetic silencing. It is suitable for assays like ChIP-qPCR, immunofluorescence, RNA-seq, and functional analyses of proliferation and cell cycle.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    CaSki

    Sex of Donor

    Female

    Age

    40 years

    Derived From Site

    Metastatic; Small intestine

    Gene Name

    CBX5

    Gene Identifier

    NCBI Gene ID 23468

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CBX5 Knockout Ca Ski Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the CBX5 gene has been disrupted to create a loss-of-function model for heterochromatin protein 1 alpha (HP1??). This polyclonal population preserves the genetic diversity inherent to CRISPR-mediated gene editing, delivering a robust tool for investigating HP1??-dependent chromatin regulation and transcriptional silencing in a human cervical carcinoma background. The knockout cells are suitable for a wide range of functional assays, including epigenetic drug screening and mechanistic studies of heterochromatin biology.

The host cell line, Ca Ski, is an epithelial cell line derived from a cervical epidermoid carcinoma metastasis and is widely employed as a model for cervical cancer research. These cells harbor integrated human papillomavirus (HPV) genomes and exhibit characteristics of malignant transformation, including genomic instability and deregulated cell cycle control. The Ca Ski background provides a clinically relevant context for examining how heterochromatin perturbations contribute to oncogenic phenotypes and therapeutic vulnerability.

CBX5 functions as a reader of trimethylated histone H3 lysine 9 (H3K9me3), a hallmark modification of constitutive heterochromatin. It is recruited to methylated chromatin by upstream methyltransferases such as SUV39H1 and SETDB1, where it interacts with partners including Lamin B receptor, DNMT1, and MeCP2 to promote chromatin compaction and transcriptional repression. CBX5 activity is further modulated by phosphorylation by kinases like PIM1 and ATM/ATR in the DNA damage response. Downstream, CBX5-mediated silencing affects pericentromeric heterochromatin regions and target gene expression, forming part of a network also involving CBX1 (HP1??) and CBX3 (HP1??).

Disruption of CBX5 in Ca Ski cells is expected to relieve heterochromatin-mediated transcriptional silencing, potentially reactivating genes that contribute to cell cycle progression, apoptosis, and genomic integrity. This model enables detailed investigation of how HP1?? loss influences cervical carcinoma cell behavior, including altered chromatin organization and expression of tumor-relevant loci. The polyclonal knockout population is particularly valuable for studying heterogeneous cellular responses to loss of heterochromatin maintenance.

The CBX5 Knockout Ca Ski Polyclonal Cells support diverse research applications, from fundamental studies of epigenetic gene regulation to translational cancer research. Example assays include ChIP-qPCR for H3K9me3 enrichment, immunofluorescence detection of heterochromatin foci, RNA-seq for transcriptome-wide changes, Western blotting for HP1?? and downstream targets, and functional tests such as proliferation, migration, and flow cytometry-based cell cycle analysis. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)